Protalix BioTherapeutics (PLX) Accounts Payables (2010 - 2026)
Protalix BioTherapeutics (PLX) reported Accounts Payables of $6.51 million for Q2 2026, down 2.7% from $6.69 million a year earlier but up 51.8% from the prior quarter.
Protalix BioTherapeutics (PLX) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics posted Accounts Payables of $5.26 million, up 16.0% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -6.1% (FY2020 to FY2025).
- By year, Accounts Payables came in at $4.53 million in FY2024 (+4.9%), $4.32 million in FY2023 (-26.3%), $5.86 million in FY2022 (-16.1%) and $6.99 million in FY2021 (-3.3%).
- Five-year quarterly Accounts Payables spans a low of $3.11 million in Q3 2023 and a high of $8.44 million in Q3 2021.
- Year over year, Accounts Payables gained in seven of the last eight quarters, with growth averaging 23.7%.
- The high point for year-over-year Accounts Payables in five years was Q3 2025 (growth of 71.5%); the low point was Q2 2023 (a decline of 52.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.29 million (Q1 2026), $5.26 million (Q4 2025) and $5.38 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.71 Bn | 1,105.29 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 617.55 Bn | 536.07 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.02 Bn | 474.13 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 368.18 Bn | 322.56 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 297.89 Bn | 261.88 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.60 Bn | 191.99 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.77 Bn | 116.42 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Protalix BioTherapeutics | 203.57 Mn | 52.18 Mn | 12.13 Mn | 6.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.51 Mn |
| Mar 31, 2026 | 4.29 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 5.86 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 6.99 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 6.99 Mn |
| Sep 30, 2021 | 8.44 Mn |
Protalix BioTherapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=PLX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();